|
⚲
|
| Keyboard |
| Harmon Seth
✚
|
|
|---|---|
| CIK # | 0001993300 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001993300] | |
| 4 | [0001993300] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Miragen Therapeutics Inc | |
| Harmon Seth |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Miragen Therapeutics Inc VRDN
Common Stock
|
2026-03-03 | Option exercise | 6,267 | ||
|
Miragen Therapeutics Inc VRDN
Restricted Stock Units · derivative
|
2026-03-03 | Option exercise | 6,267 | $0.00 | |
|
Miragen Therapeutics Inc VRDN
Common Stock
|
2026-03-03 | Tax withheld | 2,091 | $29.32 | 61,308 |
|
Miragen Therapeutics Inc VRDN
Restricted Stock Units · derivative
|
2026-03-02 | Grant | 20,550 | $0.00 | |
|
Miragen Therapeutics Inc VRDN
Stock Option (Right to Buy) · derivative
|
2026-03-02 | Grant | 102,850 | $0.00 | |
|
Miragen Therapeutics Inc VRDN
Stock Option (Right to Buy) · derivative
|
2025-03-03 | Grant | 150,407 | $0.00 | |
|
Miragen Therapeutics Inc VRDN
Restricted Stock Units · derivative
|
2025-03-03 | Grant | 25,068 | $0.00 | |
|
Miragen Therapeutics Inc VRDN
Stock Option (Right to Buy) · derivative
|
2023-11-10 | Grant | 270,000 | $0.00 |